Dr Agarwals Eye Hospital Limited

Healthcare · Healthcare Services

NSE: DRAGARWQ BSE: 526783
₹5130.00
▲ 0.50 (0.01%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
81/100
Strong
Valuation
35/100
Fairly Valued
Momentum
21/100
Bearish

QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Dr. Agarwal's Eye Hospital is a chain of eye specialty hospitals in India, headquartered in Chennai. It was founded by Dr. Jaiveer Agarwal and his wife Dr. Tahira Agarwal as an eye care centre in Chennai. It has grown to 180+ centres across India and 15 centres overseas.

Source: Wikipedia

Key Metrics

Market Capitalization
₹2,479 Cr
PE (TTM)
32.3
Industry median 50.2 (44 companies)
Price to Book
7.2
PEG (TTM)
1.1
Institutions holding %
4.29%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
7.4
Relative return vs Sector, qtr %
4.4
Free Cash Flow
₹47 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
31.75%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
31.87%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
20.01%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
35.46%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
22.28%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.23
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.24
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
10.66
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
16.35%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
23.59%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
22.51%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
9.15%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
16.10%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
20.24%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

6 of 7 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.24)
  • Yes Return on equity is 15% or more (20.2%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (7.7% pledged)

Peer comparison

2 of 2 met
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 5061.0000 · High 5201.0000
1W return
-1.4%
Low 5061.0000 · High 5300.0000
1M return
-2.6%
Low 5061.0000 · High 5500.0000
52W return
Data unavailable.
Low 4600.0000 · High 6059.7000
Lifetime High ₹5422.5000 (Sept. 4, 2026)
Lifetime Low ₹4787.8500 (April 20, 2026)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish4
5D
5162.5
10D
5194.3
20D
5226.1
50D
5213.0
100D
5128.6

Delivery and volume

Day avg. delivery
67.1%
Week avg. delivery
64.3%
Month avg. delivery
73.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

5130.67
Pivot
First resistance5200.33
Second resistance5270.67
Third resistance5340.33
First support5060.33
Second support4990.67
Third support4920.33
Day RSI43.0
Day MFI24.9
Day MACD-27.58
Day MACD signal-8.29

Beta

1M1.15
3M0.50
1Y0.31
3Y0.31

Price change analysis

↓ -2.6%
Over 1 Month
LowHigh
5061.005500.00
↑ 1.6%
Over 3 Months
LowHigh
4813.505600.00
—
Over 6 Months
LowHigh
4600.006059.70
—
Over 1 Year
LowHigh
4600.006059.70
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹143 Cr
Net profit (June 30, 2026)
₹23 Cr
Basic EPS (June 30, 2026)
₹48.3800

Ranks #26 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter72.67%
  • Mutual funds0.03%
  • FII/FPI2.24%
  • Other DII2.02%
  • Public23.04%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 72.67% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 2.20% to 2.24% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.03% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
3 Mar 2025 KIFTAR IN LLC Bulk Sell 42,247 3707.0000 BSE
3 Mar 2025 MALABAR INDIA FUND LIMITED Bulk Buy 54,000 3707.0000 BSE
8 Dec 2021 SUNITA AGARWAL . Bulk Sell 23,841 787.4200 BSE
22 Mar 2012 PAT FINANCIAL CONSULTANT PVT LTD Bulk Sell 24,500 60.4700 BSE
21 Feb 2012 FORRESTER SECURITIES PRIVATE LIMITED Bulk Sell 28,267 140.9500 BSE
16 Feb 2012 RAJASTHAN GLOBAL SECURITIES LTD Bulk Sell 41,457 148.7500 BSE
3 Feb 2012 DISCOVERY WEALTH MANAGEMENT SERVICES PRIVATE LIMITED Bulk Sell 200,000 146.3000 BSE
3 Feb 2012 AMIT GOEL Bulk Buy 200,500 146.3000 BSE
2 Feb 2012 BHARAT JAYANTILAL PATEL Bulk Sell 220,715 152.0000 BSE
2 Feb 2012 PAT FINANCIAL CONSULTANT PVT LTD Bulk Buy 221,015 151.9900 BSE

All bulk and block deals →

Last 12 months ₹4.00 per share
Dividend yield 0.08%
Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 4.0000 — —
2 Sep 2026 Dividend - Rs 4 Per Share 4.0000 2 Sep 2026

Corporate Announcements

All 3 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Dr Agarwals Eye Hospital Ltd-$ - 526783 - Closure of Trading Window
10 Sep 2026 AGM/EGM Dr Agarwals Eye Hospital Ltd-$ - 526783 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
9 Sep 2026 AGM/EGM Dr Agarwals Eye Hospital Ltd-$ - 526783 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.24)
  • Comfortable interest coverage (10.7x)
  • Strong revenue growth YoY (22.3%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Dr Agarwals Eye Hospital Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.